Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Frontiers in Health Services|October 13, 2025
Documenting adaptations across the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science research programs: methods and adaptation examplesBorsika A Rabin, Erin S Kenzie, Jill M Oliveri, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 7, 2022
A questionnaire to collect unintended effects of transcranial magnetic stimulation: A consensus based approachA Giustiniani, A Vallesi, M Oliveri, et al.
Journal of the National Cancer Institute|February 22, 2023
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiativeGloria D Coronado, Renée M Ferrari, Autumn Barnes, et al.
Nature Cancer|March 29, 2025
Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockadeXavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, et al.
Trials|October 31, 2019
European survey on national training activities in clinical researchA Magnin, V Cabral Iversen, G Calvo, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Osteoarthritis and Cartilage|January 11, 2005
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritisR D Altman, E Abadie, B Avouac, et al.
Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.
Pageof 24